Skip to content

Pathogenic Study of Adult Immune Enteropathies

Pathogenic Study of Adult Immune Enteropathies

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT04280510
Acronym
ENTEROPATH
Enrollment
200
Registered
2020-02-21
Start date
2020-02-27
Completion date
2033-02-27
Last updated
2025-09-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autoimmune Enteropathy, Celiac Disease, Inflammatory Bowel Diseases

Keywords

Celiac Disease, Autoimmune enteropathy, Primary immunodeficiency, Intestinal lymphoma, Liver autoimmune diseases

Brief summary

The study focuses the mechanisms underlying the loss of intestinal homeostasis in celiac disease, refractory celiac disease and other immune diseases such as monogenic enteropathy, inflammatory bowel diseases or drug induced intestinal diseases. Mechanisms of transformation of lymphocytes leading to onset of lymphomatous complications of immune enteropathies will be investigated. Mechanisms of loss of hepatic lymphocytic homeostasis will also be assessed in liver associated diseases.

Interventions

GENETICBlood sample collection; gastrointestinal biopsy

Targeted Next generation sequencing and whole exome sequencing Phenotyping of intestinal lymphocytes, single cell analyses, cytokines dosage...

Sponsors

Imagine Institute
CollaboratorOTHER
Institut National de la Santé Et de la Recherche Médicale, France
Lead SponsorOTHER_GOV

Study design

Observational model
COHORT
Time perspective
PROSPECTIVE

Eligibility

Sex/Gender
ALL
Age
18 Years to No maximum
Healthy volunteers
Yes

Inclusion criteria

* 18 years or over * affiliated to social insurance * signed informed consent

Exclusion criteria

* pregnancy * under guardianship * not able to sign informed consent

Design outcomes

Primary

MeasureTime frameDescription
Intestinal Lymphocytes countBaselineLymphocytes isolation
DNA sequencingBaselineTargeted Next Generation sequencing

Countries

France

Contacts

Primary ContactGeorgia MALAMUT, MD, PhD
georgia.malamut@aphp.fr33 1 58 41 41 76
Backup ContactAnaïs LEVESCOT, MD, PhD
anais.levescot@inserm.fr33 1 42 75 42 77

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026